Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02967068 · ClinicalTrials.gov registry record
VCRC Tissue Repository
A clinical trial of Giant Cell Arteritis and IgA Vasculitis, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 8
- Study locations
NCT02967068: Recruiting study of Giant Cell Arteritis and IgA Vasculitis, sponsored by University of Pennsylvania.
NCT02967068 is a study of Giant Cell Arteritis and IgA Vasculitis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,000 participants, above the 907-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (10% higher). The trial reports 8 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02967068, a study of Giant Cell Arteritis and IgA Vasculitis, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of translational research projects. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.
Primary Outcome
Evaluating of clinical data and linked biopsy specimens to identify genes that increase the risk of developing vasculitis.
Conditions Studied
Study Locations (8)
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston University School of Medicine - Boston
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Ontario
- St. Joseph's Healthcare - Hamilton
- University of Toronto Mount Sinai Hospital - Toronto
Ohio
- Cleveland Clinic - Cleveland
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-11 |
| Est. Completion | 2028-12 |
What NCT02967068 shows while recruiting
NCT02967068 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 907-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (10% higher).
The record links to 10 conditions, with Giant Cell Arteritis appearing as the primary indexed condition, and to 0 interventions.
NCT02967068 lists 8 locations in 5 states (Massachusetts, Pennsylvania, Ontario).
Frequently Asked Questions
What is clinical trial NCT02967068 about?
NCT02967068 is a clinical study titled "VCRC Tissue Repository". The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of...
What is the current status of trial NCT02967068?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-11. Estimated completion is 2028-12.
What conditions does trial NCT02967068 study?
This clinical trial studies the following conditions: Giant Cell Arteritis, IgA Vasculitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis With Polyangiitis, Polyarteritis Nodosa.
Who is sponsoring clinical trial NCT02967068?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02967068 being conducted?
This trial has 8 study locations across Massachusetts, Ohio, Pennsylvania, Utah, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Giant Cell Arteritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
RECRUITING
-
One-Time DNA Study for Vasculitis
RECRUITING
-
Abatacept for the Treatment of Giant Cell Arteritis
RECRUITING · Phase 3
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
RECRUITING
-
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
COMPLETED · Phase 2
-
Vasculitis Illness Perception (VIP) Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia